奕安济世 - 值得信赖的大分子药物CDMO
奕安济世, HJB, CDMO, biologics, 杭州奕安济世生物药业有限公司, 奕安济世官网, 杭州奕安济世
Sep, 2025
Sep, 2025
Highlights This talk will hlight HJB's journey developing and implementing hybrid continuous bioprocessing enabling a next-gen platform to meet business and patient needs. HJB's Breakthroughs in Hybrid Continuous Bioprocessing: ▪ Continuous perfusion platform achieving >10-fold productivity gains (up to 8 g/L-day) ▪ Integrated continuous single-use Protein A capture with robust bioburden control ▪ Fully automated, single-use flow-through polishing system ▪ Demonstrated process and product comparability Join us to explore how hybrid continuous bioprocessing is reshaping the future of biomanufacturing. If you're interested in this transformative technology, please contact bd@hjbbio.com or call us at 13601691087/ 0571-2827 9502*8555 to learn more. We look forward to connecting with you! 推荐阅读
关于奕安济世 About HJB 奕安济世具有丰富的细胞系开发、工艺开发、临床样品生产及放行、IND/BLA申报的全流程经验。奕安济世在杭州拥有工艺开发中心及符合cGMP标准的原液及成品生产车间，通过技术的不断创新及稳定的连续化生产工艺，可极大缩短工艺开发进程和降低生产成本，为生物药创新合作伙伴提供优质、可靠、快速的CDMO服务。 我们与客户共赢，我们与时代共进。 业务咨询： BD@hjbbio.com | 13601691087 | 0571-2827 9502*8555
BD@hjbbio.com
0571-2827-9502*8555
